knowledge -WSS

knowledge

author：leisure time 2025-09-28 01:37:41 - browse：1473

Jamy Ard (left) and Robert Lustig (right) on the 2023 STAT Breakthrough Summit stage -- coverage from STAT — Obesity experts Jamy Ard (left) and Robert Lustig speak at a panel during the 2023 STAT Breakthrough Summit. Sarah Gonzalez for STAT

Amid rising demand for drugs like Wegovy, Ozempic, and Mounjaro that can lead to significant weight loss, some obesity experts are concerned about the drugs’ costs — both to patients’ finances and to their health.

Speaking at a panel on new obesity treatments at the STAT Breakthrough Summit in San Francisco on Thursday, one expert cited a large clinical trial for Wegovy that showed that about 40% of the weight participants lost was lean mass. Side effects like nausea, vomiting, and a possible link to rare cases of pancreatitis also still plague this newest class of drugs, which imitate the effects of a hormone called glucagon-like peptide 1 (GLP) that helps people feel full.

“That’s what starvation does. You lose equal amounts of muscle and fat,” said Robert Lustig, emeritus professor of pediatrics at the University of California, San Francisco. “If you’re a person 60 years old or over and you’re losing muscle, your risk of dying just went up exponentially. So we may be … robbing Peter to pay Paul.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Microsoft's Peter Lee: Generative AI could help doctors be more human

explore

WSS

STAT Summit: The economic case for universal basic health care

Readout Newsletter: BridgeBio, Akero, and human embryo models

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

First over

Stem cell biologist probes earliest stages of human development

The untold story of TV’s first prescription drug ad

entertainment

knowledge

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

How AI can help patients find reliable information about doctors

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout Newsletter: BridgeBio, Akero, and human embryo models

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Why a market frenzy over new weight loss drugs defies logic

Medical records are filled with copy

UnitedHealth, Optum discontinue NaviHealth name

After affirmative action ruling, medical educators look to 'holistic review'

How AI can help patients find reliable information about doctors

entertainment

Families look for replacement for GSK asthma drug Flovent

Families look for replacement for GSK asthma drug Flovent

For AI in health care standards, federal regulators join with industry group

Readout LOUD podcast: Live from the 2023 STAT Summit

Health tech investors get more selective as pandemic boom fades

Is there really a nursing shortage in the U.S.?

knowledge

explore

focus

hotspot